Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Biohaven Pharmaceutical Holding Co Ltd. | Chief Executive Officer, Director | Common Shares | 831K | $123M | $148.50 | Oct 3, 2022 | Direct |
Biohaven Ltd. | Chief Executive Officer, Director | Common Shares | 1.79M | $85M | $47.50 | Oct 2, 2024 | Direct |
Biohaven Pharmaceutical Holding Co Ltd. | Chief Executive Officer, Director | Common Shares | 517K | $76.8M | $148.50 | Oct 3, 2022 | By: The Vladimir Coric Marital Trust |
Biohaven Pharmaceutical Holding Co Ltd. | Chief Executive Officer, Director | Common Shares | 498K | $74M | $148.50 | Oct 3, 2022 | By 401(K) Plan |
Biohaven Ltd. | Chief Executive Officer, Director | Common Shares | 862K | $40.9M | $47.50 | Oct 2, 2024 | By: The Vlad Coric Family Trust |
Biohaven Ltd. | Chief Executive Officer, Director | Common Shares | 407K | $19.3M | $47.50 | Oct 2, 2024 | By: The Vladimir Coric Marital Trust |
Biohaven Ltd. | Chief Executive Officer, Director | Common Shares | 110K | $5.2M | $47.50 | Oct 2, 2024 | By: 401(K) Plan |
Revance Therapeutics, Inc. | Director | Common Stock | 20.8K | $79K | $3.80 | May 1, 2024 | Direct |
Biohaven Ltd. | Chief Executive Officer, Director | Stock Options (Right to buy) | 275K | Jan 2, 2024 | Direct | ||
Revance Therapeutics, Inc. | Director | Stock Option (Right to buy) | 23.5K | May 1, 2024 | Direct | ||
Biohaven Pharmaceutical Holding Co Ltd. | Chief Executive Officer, Director | Common Shares | 0 | $148.50 | Oct 3, 2022 | By: The Vladimir Coric Family Trust | |
Biohaven Pharmaceutical Holding Co Ltd. | Chief Executive Officer, Director | Restricted Share Unit Award | 0 | Oct 3, 2022 | Direct | ||
Biohaven Pharmaceutical Holding Co Ltd. | Chief Executive Officer, Director | Stock Options (Right to Buy) | 0 | Oct 3, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BHVN | Biohaven Ltd. | Oct 2, 2024 | 1 | $1M | 4 | Oct 3, 2024 | Chief Executive Officer, Director |
RVNC | Revance Therapeutics, Inc. | May 1, 2024 | 2 | $0 | 4 | May 3, 2024 | Director |
BHVN | Biohaven Ltd. | Apr 22, 2024 | 1 | $5M | 4 | Apr 23, 2024 | Chief Executive Officer, Director |
BHVN | Biohaven Ltd. | Apr 5, 2024 | 3 | $0 | 4 | Apr 5, 2024 | Chief Executive Officer, Director |
BHVN | Biohaven Ltd. | Mar 8, 2024 | 3 | $0 | 4 | Mar 8, 2024 | Chief Executive Officer, Director |
BHVN | Biohaven Ltd. | Jan 8, 2024 | 3 | $0 | 4 | Jan 10, 2024 | Chief Executive Officer, Director |
BHVN | Biohaven Ltd. | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Chief Executive Officer, Director |
BHVN | Biohaven Ltd. | Nov 2, 2023 | 1 | $0 | 4 | Nov 6, 2023 | Chief Executive Officer, Director |
BHVN | Biohaven Ltd. | Oct 5, 2023 | 2 | $10M | 4 | Oct 10, 2023 | Chief Executive Officer, Director |
RVNC | Revance Therapeutics, Inc. | May 3, 2023 | 2 | $0 | 4 | May 5, 2023 | Director |
RVNC | Revance Therapeutics, Inc. | Mar 1, 2023 | 2 | $0 | 4 | Mar 3, 2023 | Director |
RVNC | Revance Therapeutics, Inc. | Mar 1, 2023 | 0 | $0 | 3 | Mar 3, 2023 | Director |
BHVN | Biohaven Ltd. | Oct 31, 2022 | 1 | $412K | 4 | Nov 1, 2022 | Chief Executive Officer, Director |
BHVN | Biohaven Ltd. | Oct 28, 2022 | 2 | $2.11M | 4 | Oct 31, 2022 | Chief Executive Officer, Director |
BHVN | Biohaven Ltd. | Oct 25, 2022 | 1 | $8.96M | 4 | Oct 26, 2022 | Chief Executive Officer, Director |
BHVN | Biohaven Ltd. | Oct 5, 2022 | 9 | $5.01M | 4 | Oct 6, 2022 | Chief Executive Officer, Director |
BHVN | Biohaven Ltd. | Oct 3, 2022 | 1 | $0 | 4/A | Oct 12, 2022 | Chief Executive Officer, Director |
BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Oct 3, 2022 | 26 | -$137M | 4 | Oct 3, 2022 | Chief Executive Officer, Director |
BHVN | Biohaven Ltd. | Sep 22, 2022 | 0 | $0 | 3 | Sep 28, 2022 | Chief Executive Officer, Director |
BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Jan 6, 2022 | 8 | -$1.32M | 4 | Jan 7, 2022 | Chief Executive Officer, Director |
BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Dec 31, 2021 | 4 | $0 | 5 | Feb 11, 2022 | Chief Executive Officer, Director |
BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Nov 25, 2021 | 3 | -$586K | 4 | Nov 26, 2021 | Chief Executive Officer, Director |
AKLI | Social Capital Suvretta Holdings Corp. I | Jun 29, 2021 | 0 | $0 | 3 | Jun 29, 2021 | Director |